Search for: "Pharmaceuticals USA, Inc." Results 81 - 100 of 917
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Aug 2021, 6:20 am by Robert Kraft
” With the “settlements, only three drug manufacturers, Endo Health Solutions, Teva Pharmaceuticals USA and Allergan Finance, remain at trial. [read post]
29 Jul 2021, 11:02 am by Dennis Crouch
Hikma Pharmaceuticals USA Inc., Docket No. 21-02024 (Fed. [read post]
21 Jul 2021, 12:44 pm by Jon L. Gelman
The manufacturers named in the complaint included Purdue Pharma and its affiliates, as well as members of the Sackler Family (owners of Purdue) and trusts they control; Janssen Pharmaceuticals and its affiliates (including its parent company Johnson & Johnson); Mallinckrodt LLC and its affiliates; Endo Health Solutions and its affiliates; Teva Pharmaceuticals USA, Inc. and its affiliates; and Allergan Finance, LLC and its affiliates. [read post]
25 Jun 2021, 4:15 am by Logan Murr
(Amgen) in their case against Sanofi, Aventisub LLC, FKA Aventis Pharmaceuticals Inc., Regeneron Pharmaceuticals Inc., and Sanofi-Aventis U.S. [read post]
25 Jun 2021, 4:15 am by Logan Murr
(Amgen) in their case against Sanofi, Aventisub LLC, FKA Aventis Pharmaceuticals Inc., Regeneron Pharmaceuticals Inc., and Sanofi-Aventis U.S. [read post]
7 Jun 2021, 6:55 am by Dennis Crouch
Hikma Pharmaceuticals USA Inc., No. 20-1119; Attorney Fees: Roadie, Inc. v. [read post]
30 Apr 2021, 8:07 am by Dan Bressler
Barclay Surrick to require Morgan Lewis to answer a series of questions about its ability to ethically represent Glenmark Pharmaceuticals Inc. [read post]
30 Apr 2021, 3:26 am
  May 18, 2021 - 11 AM: In re BFY LLC, Serial No. 88606855 [Section 2(e)(1) refusal to register the mark MULTEEZ for "Homeopathic pharmaceuticals, namely, vitamins," on the ground of mere descriptiveness.]May 25 2021 - 1 PM: In re Herman Miller, Inc., Serial No. 88027008 [Refusal to register a three-dimensional product configuration of a chair on the ground of de jure functionality under Section 2(e)(5).] [read post]
15 Apr 2021, 10:51 am by Dennis Crouch
Hikma Pharmaceuticals USA Inc., et al., No. 20-1119 (secondary indicia); Sandoz Inc., et al. v. [read post]
4 Jan 2021, 2:02 pm by Cynthia Marcotte Stamer
  The indictment also alleges that, with the proceeds of the fraud, the defendants engaged in a complex money laundering conspiracy where they created sham pharmacy wholesale companies, which they named after pre-existing pharmacy wholesalers, and fabricated invoices to make it appear that funds transferred from the pharmacies to the sham pharmacy wholesale companies  were for legitimate pharmaceutical drug purchases. [read post]